AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.45
(7.93%)
AUD 2.45
(7.93%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 62.63 Million NZD | 59.96% |
| 2023 | 54.32 Million NZD | 33.61% |
| 2022 | 40.65 Million NZD | 8.66% |
| 2021 | 37.41 Million NZD | 31.51% |
| 2020 | 28.45 Million NZD | -24.4% |
| 2019 | 37.63 Million NZD | -15.6% |
| 2018 | 44.59 Million NZD | 7.48% |
| 2017 | 41.48 Million NZD | 22.96% |
| 2016 | 33.74 Million NZD | 4.13% |
| 2015 | 32.4 Million NZD | 57.59% |
| 2014 | 20.56 Million NZD | 22.98% |
| 2013 | 16.72 Million NZD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 32.18 Million NZD | 10.37% |
| 2024 Q4 | 30.44 Million NZD | -5.39% |
| 2024 FY | 66.57 Million NZD | 22.56% |
| 2023 Q2 | 25.16 Million NZD | 28.24% |
| 2023 FY | 54.32 Million NZD | 33.61% |
| 2023 Q4 | 29.16 Million NZD | 15.89% |
| 2022 Q4 | 19.62 Million NZD | -6.73% |
| 2022 FY | 40.65 Million NZD | 8.66% |
| 2022 Q2 | 21.03 Million NZD | 4.63% |
| 2021 Q2 | 17.31 Million NZD | -15.25% |
| 2021 FY | 37.41 Million NZD | 31.51% |
| 2021 Q4 | 20.1 Million NZD | 16.15% |
| 2020 Q4 | 20.42 Million NZD | 154.5% |
| 2020 FY | 28.45 Million NZD | -24.4% |
| 2020 Q2 | 8.02 Million NZD | -54.63% |
| 2019 Q2 | 19.94 Million NZD | -20.86% |
| 2019 FY | 37.63 Million NZD | -15.6% |
| 2019 Q4 | 17.68 Million NZD | -11.32% |
| 2018 FY | 44.59 Million NZD | 7.48% |
| 2018 Q4 | 25.2 Million NZD | 30.04% |
| 2018 Q2 | 19.38 Million NZD | -7.87% |
| 2017 Q2 | 20.44 Million NZD | 3.79% |
| 2017 Q4 | 21.04 Million NZD | 2.89% |
| 2017 FY | 41.48 Million NZD | 22.96% |
| 2016 Q2 | 14.04 Million NZD | -26.66% |
| 2016 FY | 33.74 Million NZD | 4.13% |
| 2016 Q4 | 19.7 Million NZD | 40.33% |
| 2015 Q4 | 19.14 Million NZD | 44.34% |
| 2015 FY | 32.4 Million NZD | 57.59% |
| 2015 Q2 | 13.26 Million NZD | 0.0% |
| 2014 FY | 20.56 Million NZD | 22.98% |
| 2013 FY | 16.72 Million NZD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Althea Group Holdings Limited | 17.46 Million AUD | -258.641% |
| Cann Group Limited | 15.37 Million AUD | -307.422% |
| ECS Botanics Holdings Ltd | 6.07 Million AUD | -931.201% |
| Ecofibre Limited | 24.94 Million AUD | -151.054% |
| Elixinol Wellness Limited | 3.42 Million AUD | -1731.374% |
| Hygrovest Limited | 260 Thousand AUD | -23989.615% |
| IDT Australia Limited | 12.44 Million AUD | -403.319% |
| Invion Limited | 8.55 Million AUD | -632.083% |
| Little Green Pharma Ltd | 25.38 Million AUD | -146.73% |
| Live Verdure Ltd | 13.23 Million AUD | -373.197% |
| Medical Developments International Limited | 24.36 Million AUD | -157.051% |
| Vitura Health Limited | 29.35 Million AUD | -113.381% |
| Vita Life Sciences Limited | 30.38 Million AUD | -106.104% |